A team of ChEM-H fellows have resurrected a discarded drug that helps human cells in a lab dish fight off two different viruses. Based on what they learned about how the drug works, it might also help fight the viruses that cause Ebola, dengue and Zika, among others.
ChEM-H Faculty Fellow Ami Bhatt is mobilizing Stanford experts to fight the growing threat of cancer in the developing world.
ChEM-H Faculty Fellow Carolyn Bertozzi has developed a new diagnostics tool with broad applicability.
ChEM-H is seeking applicants for a tenured or tenure-track faculty position at any level (Assistant, Associate, or Full Professor). Applicants are expected to have an M.D. or M.D./Ph.D. degree and be board certified or eligible in any medical specialty.
ChEM-H Faculty Fellow Matthew Bogyo has designed a compound that targets the malaria parasite in human cells without harming human tissue.
Stanley Qi is gaining attention for his work to modify the popular gene-editing enzyme CRISPR. The modified enzyme is a powerful tool to study and modulate gene function with novel therapeutic potential.
Jeffrey Glenn will lead a new center to develop new anti-viral therapies that target the host rather than the infection. The center will collaborate with ChEM-H as well as other Stanford institutes.
ChEM-H Director Chaitan Khosla discusses ChEM-H, his goals for the institute and the challenge of bridging the worlds of chemistry and biology.
Lingyin Li to join Stanford ChEM-H as assistant professor of biochemistry
Lei Stanley Qi joined Stanford ChEM-H as assistant professor of bioengineering and of chemical and systems biology
Polly Fordyce joined Stanford ChEM-H as assistant professor of genetics.
Carolyn Bertozzi joined Stanford ChEM-H as professor of chemistry and, by courtesy, of chemical and systems biology.
Peter Kim joined Stanford ChEM-H as professor of biochemistry